Skip to main content

[vc_row][vc_column][vc_single_image image="40602" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]National Foundation for Cancer Research-funded researcher Dr. Daniel A Haber recently unearthed an exciting discovery that may add years to the lives of late-stage breast cancer patients. Dr. Haber is fascinated by understanding drug resistance on a deeper level by studying...

[vc_row][vc_column][vc_single_image image="27821" img_size="full" alignment="center"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] It is the one word you do not want to hear in a cancer diagnosis: metastasis. It represents the figurative death-knell; once a cancer has spread to other parts of the body, survival rates plummet, and what treatments do exist switch from...

[vc_row][vc_column width="1/4"][vc_single_image image="23417" img_size="medium" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""]A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientist supported by...

[vc_row][vc_column][vc_single_image image="22374" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Researchers from the University of Liverpool have found an explanation for how breast cancer spreads to the lungs, which could potentially hold the key to preventing the progression of the disease. Led by Dr. Ainhoa Mielgo, the research team conducted...